![PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5e273e28-94f9-4a61-be41-3d02ba8af628/ajd13738-tbl-0001-m.jpg)
PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library
![Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology](http://dl.jddonline.com/articleimages/article_2456/table1.png)
Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology
![Figure 1 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar Figure 1 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5b5fe1753c6637c3d8d05d3474c75480496dc8b7/7-Figure1-1.png)
Figure 1 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar
![Early Treatment Targets for Predicting Long-term Dermatology Life Quality Index Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post-hoc Analysis from a Long-term Clinical Study – JCAD | The Journal of Clinical Early Treatment Targets for Predicting Long-term Dermatology Life Quality Index Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post-hoc Analysis from a Long-term Clinical Study – JCAD | The Journal of Clinical](https://jcadonline.com/wp-content/uploads/September2020BurgeTable1.jpg)
Early Treatment Targets for Predicting Long-term Dermatology Life Quality Index Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post-hoc Analysis from a Long-term Clinical Study – JCAD | The Journal of Clinical
![Janssen EMEA on Twitter: "Research suggests that absolute PASI scores can provide more clinically relevant information about the long-term severity of #psoriasis and the impact it has on a person's quality of Janssen EMEA on Twitter: "Research suggests that absolute PASI scores can provide more clinically relevant information about the long-term severity of #psoriasis and the impact it has on a person's quality of](https://pbs.twimg.com/media/EGcnburXoAI9VUZ.jpg:large)
Janssen EMEA on Twitter: "Research suggests that absolute PASI scores can provide more clinically relevant information about the long-term severity of #psoriasis and the impact it has on a person's quality of
![Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram](https://www.researchgate.net/publication/221929000/figure/fig2/AS:304724734693382@1449663446939/Psoriasis-Area-and-Severity-Index-PASI-score-assessment-H-head-LL-lower-limbs-T.png)
Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram
![Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study - Richard - 2021 - Journal of Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study - Richard - 2021 - Journal of](https://onlinelibrary.wiley.com/cms/asset/85d48eca-71ce-42ea-9c50-3f367fac9326/jdv16893-fig-0001-m.jpg)
Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study - Richard - 2021 - Journal of
![Another PASI Calculator Mobile Medical App from Janssen: Simple, Sophisticated, But Short of a Full Deck - Pharma Marketing Network Another PASI Calculator Mobile Medical App from Janssen: Simple, Sophisticated, But Short of a Full Deck - Pharma Marketing Network](http://3.bp.blogspot.com/-mJYB19N2F0g/UopwPn5ZF-I/AAAAAAAAGc4/xRJNATI2yW4/s1600/PASI-JanssenKoreaScreen.jpg)